Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Sat, August 1, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Sat, July 25, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Sun, July 19, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Fri, June 26, 2009
Thu, June 25, 2009
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009
Sun, June 21, 2009
Fri, June 19, 2009
Thu, June 18, 2009
Wed, June 17, 2009
Tue, June 16, 2009
Mon, June 15, 2009
Fri, June 12, 2009
Thu, June 11, 2009
Wed, June 10, 2009
Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009

Eurand N.V.: Eurand Announces Conference Call on Second Quarter 2009 Financial Results


//health-fitness.news-articles.net/content/2009/ .. ll-on-second-quarter-2009-financial-results.html
Published in Health and Fitness on Wednesday, July 8th 2009 at 6:21 GMT, Last Modified on 2009-07-08 06:21:51 by Market Wire   Print publication without navigation


AMSTERDAM, THE NETHERLANDS--(Marketwire - July 8, 2009) - Eurand N.V. (NASDAQ: [ EURX ]), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, will hold a conference call on Thursday, August 6, 2009 at 8:30 a.m. ET to discuss its second quarter 2009 financial results. Gearóid Faherty, Chairman and Chief Executive Officer, and Mario Crovetto, Chief Financial Officer, will host the call.

 The schedule is as follows: 7:00 a.m. ET: Second quarter 2009 financial results released 8:20 a.m. ET: Dial in to participate in the conference call: -- U.S. Participants dial 1-877-407-9039 -- International Participants dial + 1-201-689-8470 8:30 a.m. ET: Conference call begins Call Replay: A replay of the call will be available from 11:30 a.m. ET on August 6, 2009 until September 6, 2009. The Account Number is: 3055; Conference ID Number: 327788. -- U.S. Participants dial 1-877-660-6853 -- International Participants dial + 1-201-612-7415 Webcast: A live webcast of the call will be available from the Investor Relations section of the corporate web site at [ www.eurand.com ]. Following the live webcast, the archived version of the call will be available at the same URL until September 6, 2009. 

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had five products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit [ www.eurand.com ].


Publication Contributing Sources

Similar Health and Fitness Publications